Nomura Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.85M | Buy |
|
|||||
|
2025
Q1 | $5.03M | Buy |
|
|||||
|
2024
Q4 | $6.85M | Sell |
|
|||||
|
2024
Q3 | $5.64M | Buy |
|
|||||
|
2024
Q2 | $4.73M | Sell |
|
|||||
|
2024
Q1 | $4.13M | Sell |
|
|||||
|
2023
Q4 | $3.65M | Sell |
|
|||||
|
2023
Q3 | $3.71M | Buy |
|
|||||
|
2023
Q2 | $2.68M | Buy |
|
|||||
|
2023
Q1 | $3.05M | Buy |
|
|||||
|
2022
Q4 | $3.02M | Buy |
|
|||||
|
2022
Q3 | $2.36M | Buy |
|
|||||
|
2022
Q2 | $2M | Hold |
|
|||||
|
2022
Q1 | $2.49M | Buy |
|
|||||
|
2021
Q4 | $1.71M | Hold |
|
|||||
|
2021
Q3 | $2.07M | Hold |
|
|||||
|
2021
Q2 | $2.11M | Buy |
|
|||||
|
2021
Q1 | $2.18M | Sell |
|
|||||
|
2020
Q4 | $1.91M | Buy |
|
|||||
|
2020
Q3 | $1.7M | Sell |
|
|||||
|
2020
Q2 | $2.75M | Sell |
|
|||||
|
2020
Q1 | $2.08M | Sell |
|
|||||
|
2019
Q4 | $2.67M | Buy |
|
|||||
|
2019
Q3 | $1.72M | Sell |
|
|||||
|
2019
Q2 | $2.95M | Buy |
|
|||||
|
2019
Q1 | $4.29M | Sell |
|
|||||
|
2018
Q4 | $5.41M | Buy |
|
|||||
|
2018
Q3 | $6.58M | Sell |
|
|||||
|
2018
Q2 | $7.71M | Buy |
|
|||||
|
2018
Q1 | $4.38M | Sell |
|
|||||
|
2017
Q4 | $5.02M | Sell |
|
|||||
|
2017
Q3 | $6.56M | Sell |
|
|||||
|
2017
Q2 | $15.1M | Sell |
|
|||||
|
2017
Q1 | $14.7M | Sell |
|
|||||
|
2016
Q4 | $17.6M | Buy |
|
|||||
|
2016
Q3 | $20M | Sell |
|
|||||
|
2016
Q2 | $21.8M | Buy |
|
|||||
|
2016
Q1 | $22.8M | Buy |
|
|||||
|
2015
Q4 | $25.8M | Sell |
|
|||||
|
2015
Q3 | $24M | Sell |
|
|||||
|
2015
Q2 | $28.1M | Buy |
|
|||||
|
2015
Q1 | $29.1M | Sell |
|
|||||
|
2014
Q4 | $26.8M | Sell |
|
|||||
|
2014
Q3 | $25.6M | Buy |
|
|||||
|
2014
Q2 | $23.1M | Buy |
|
|||||
|
2014
Q1 | $21.5M | Sell |
|
|||||
|
2013
Q4 | $20.3M | Buy |
|
|||||
|
2013
Q3 | $18.1M | Buy |
|
|||||
|
2013
Q2 | $16.6M | Buy |
|